Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
NEOG Stock Forecast 2025-2026
$5.16
Current Price
$1.13B
Market Cap
Buy 2
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to NEOG Price Targets
+151.9%
To High Target of $13.00
+74.4%
To Median Target of $9.00
-3.1%
To Low Target of $5.00
NEOG Price Momentum
+10.0%
1 Week Change
-40.3%
1 Month Change
-57.5%
1 Year Change
-57.5%
Year-to-Date Change
-72.2%
From 52W High of $18.58
+33.3%
From 52W Low of $3.87
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Neogen (NEOG) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on NEOG and similar high-potential opportunities.
Latest NEOG Stock Price Targets & Analyst Predictions
Based on our analysis of 6 Wall Street analysts, NEOG has a bullish consensus with a median price target of $9.00 (ranging from $5.00 to $13.00). The overall analyst rating is Strong Buy (8.7/10). Currently trading at $5.16, the median forecast implies a 74.4% upside. This outlook is supported by 2 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Subbu Nambi at Guggenheim, projecting a 151.9% upside. Conversely, the most conservative target is provided by David Westenberg at Piper Sandler, suggesting a 3.1% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NEOG Analyst Ratings
2
Buy
1
Hold
0
Sell
NEOG Price Target Range
Low
$5.00
Average
$9.00
High
$13.00
Current: $5.16
Latest NEOG Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NEOG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 22, 2025 | Piper Sandler | David Westenberg | Neutral | Maintains | $5.00 |
| Apr 14, 2025 | Piper Sandler | David Westenberg | Neutral | Maintains | $6.50 |
| Apr 10, 2025 | Guggenheim | Subbu Nambi | Buy | Maintains | $13.00 |
| Jan 21, 2025 | Piper Sandler | David Westenberg | Neutral | Reiterates | $13.00 |
| Dec 19, 2024 | Guggenheim | Subbu Nambi | Buy | Initiates | $15.00 |
| Aug 6, 2024 | Piper Sandler | David Westenberg | Neutral | Maintains | $17.50 |
| Apr 15, 2024 | Piper Sandler | David Westenberg | Neutral | Maintains | $17.00 |
| Jan 18, 2024 | Piper Sandler | David Westenberg | Neutral | Maintains | $19.00 |
| Oct 16, 2023 | Piper Sandler | David Westenberg | Neutral | Maintains | $17.50 |
| Aug 14, 2023 | Wells Fargo | Timothy Daley | Overweight | Maintains | $28.00 |
| Jun 16, 2023 | Wells Fargo | Timothy Daley | Overweight | Initiates | $22.00 |
| Dec 15, 2022 | Piper Sandler | David Westenberg | Neutral | Maintains | $17.00 |
| Nov 22, 2022 | William Blair | Brandon Vazquez | Outperform | Upgrade | $0.00 |
| Oct 10, 2022 | Piper Sandler | David Westenberg | Neutral | Maintains | $14.00 |
| Aug 30, 2022 | Piper Sandler | David Westenberg | Neutral | Maintains | $20.00 |
| Aug 1, 2022 | Piper Sandler | David Westenberg | Neutral | Maintains | $26.00 |
| Jul 12, 2022 | Piper Sandler | Neutral | Initiates | $0.00 | |
| Mar 19, 2019 | Craig-Hallum | Buy | Upgrade | $0.00 | |
| Mar 27, 2018 | Stephens & Co. | Drew Jones | Equal-Weight | Maintains | $65.00 |
| Jul 14, 2017 | CL King | Neutral | Initiates | $0.00 |
Neogen Corporation (NEOG) Competitors
The following stocks are similar to Neogen based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Neogen Corporation (NEOG) Financial Data
Neogen Corporation has a market capitalization of $1.13B with a P/E ratio of 865.0x. The company generates $906.00M in trailing twelve-month revenue with a -53.6% profit margin.
Revenue growth is -3.4% quarter-over-quarter, while maintaining an operating margin of +2.5% and return on equity of -16.7%.
Valuation Metrics
Market Cap
$1.13B
Enterprise Value
$1.89B
P/E Ratio
865.0x
PEG Ratio
8.7x
Price/Sales
1.2x
Growth & Margins
Revenue Growth (YoY)
-3.4%
Gross Margin
+49.9%
Operating Margin
+2.5%
Net Margin
-53.6%
EPS Growth
-3.4%
Financial Health
Cash/Price Ratio
+11.4%
Current Ratio
3.9x
Debt/Equity
33.6x
ROE
-16.7%
ROA
+0.6%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Neogen Corporation (NEOG) Business Model
About Neogen Corporation
What They Do
Develops food and animal safety solutions.
Business Model
Neogen Corporation generates revenue by providing a wide array of products including diagnostic tests, vitamins, pharmaceuticals, and disinfectants aimed at enhancing safety and compliance in the food and animal industries. Their offerings cater to various sectors such as agrochemical, veterinary, and food production, creating a diverse revenue stream.
Additional Information
Founded in 1981 and based in Lansing, Michigan, Neogen has established itself as a key player in the global food supply chain. The company's focus on rapid pathogen detection and livestock productivity not only addresses safety concerns but also contributes to public health and agricultural sustainability.
Company Information
Sector
Healthcare
Industry
Diagnostics & Research
Employees
2,917
CEO
Mr. John Edward Adent
Country
United States
IPO Year
1994
Website
www.neogen.comNeogen Corporation (NEOG) Latest News & Analysis
Latest News
Neogen: A Fair Divestment (Rating Upgrade)
5 days ago
Quick Summary
Neogen's merger with 3M Food Safety resulted in debt and operational issues, leading to a CEO ousting. The company is considering asset sales and restructuring, presenting a speculative investment opportunity.
Why It Matters
Neogen's merger challenges led to debt and leadership changes, impacting share value. Asset sales and restructuring could stabilize the company, presenting a speculative investment opportunity.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Neogen Corporation (NASDAQ: NEOG) has agreed to sell its global cleaners and disinfectants business to Kersia Group for $130 million in cash, with additional contingent payments based on future performance.
Why It Matters
Neogen's sale of its cleaners and disinfectants business for $130 million enhances cash flow and focuses on core strengths, potentially improving margins and future earnings.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
NEOG reported third-quarter fiscal 2025 earnings and revenues that fell below expectations.
Why It Matters
Lower-than-expected earnings and revenues for NEOG signal potential financial instability, which may lead to decreased investor confidence and a drop in stock price.
Source: Zacks Investment Research
Market Sentiment:
Negative
Neogen Q3 Earnings Fall Short On Expectations, Cuts Guidance Amid Macro Headwinds And Tariff Concerns
19 days ago
Quick Summary
Neogen Corp. reported Q3 2025 adjusted EPS of 10 cents, down from 12 cents year-over-year and below the consensus estimate of 11 cents.
Why It Matters
Neogen Corp.'s lower EPS and miss on consensus indicate potential financial weakness, which may lead to reduced investor confidence and impact stock performance.
Source: Benzinga
Market Sentiment:
Negative
Quick Summary
U.S. stocks showed mixed performance, with the Dow Jones index declining over 100 points during midday trading on Wednesday.
Why It Matters
Mixed trading and a decline in the Dow Jones indicate market volatility, potentially affecting investor sentiment and influencing decisions on stock positions.
Source: Benzinga
Market Sentiment:
Negative
Quick Summary
Neogen Corporation (NASDAQ:NEOG) will hold its Q3 2025 earnings conference call on April 9, 2025, at 8:00 AM ET, featuring CEO John Adent and CFO David Naemura.
Why It Matters
Neogen's Q3 earnings call provides insights into financial performance and strategic direction, crucial for assessing stock valuation and future growth potential.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About NEOG Stock
What is Neogen Corporation's (NEOG) stock forecast for 2025?
Based on our analysis of 6 Wall Street analysts, Neogen Corporation (NEOG) has a median price target of $9.00. The highest price target is $13.00 and the lowest is $5.00.
Is NEOG stock a good investment in 2025?
According to current analyst ratings, NEOG has 2 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $5.16. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NEOG stock?
Wall Street analysts predict NEOG stock could reach $9.00 in the next 12 months. This represents a 74.4% increase from the current price of $5.16. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Neogen Corporation's business model?
Neogen Corporation generates revenue by providing a wide array of products including diagnostic tests, vitamins, pharmaceuticals, and disinfectants aimed at enhancing safety and compliance in the food and animal industries. Their offerings cater to various sectors such as agrochemical, veterinary, and food production, creating a diverse revenue stream.
What is the highest forecasted price for NEOG Neogen Corporation?
The highest price target for NEOG is $13.00 from Subbu Nambi at Guggenheim, which represents a 151.9% increase from the current price of $5.16.
What is the lowest forecasted price for NEOG Neogen Corporation?
The lowest price target for NEOG is $5.00 from David Westenberg at Piper Sandler, which represents a -3.1% decrease from the current price of $5.16.
What is the overall NEOG consensus from analysts for Neogen Corporation?
The overall analyst consensus for NEOG is bullish. Out of 6 Wall Street analysts, 2 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $9.00.
How accurate are NEOG stock price projections?
Stock price projections, including those for Neogen Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 28, 2025 6:03 PM UTC